Guimbellot JS - Search Results

1

Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL).

Baker E, Harris WT, Guimbellot JS, Bliton K, Rowe SM, Raju SV, Oates GR. Baker E, et al. Among authors: guimbellot js. J Cyst Fibros. 2024 Sep;23(5):959-966. doi: 10.1016/j.jcf.2024.07.010. Epub 2024 Jul 20. J Cyst Fibros. 2024. PMID: 39033068

2

Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis.

Poore TS, Virella-Lowell I, Guimbellot JS. Poore TS, et al. Among authors: guimbellot js. Pediatr Pulmonol. 2018 Jul;53(7):E21-E23. doi: 10.1002/ppul.24043. Epub 2018 May 23. Pediatr Pulmonol. 2018. PMID: 29790674 Free PMC article.

3

Highlights from the 2019 North American Cystic Fibrosis Conference.

Hoppe JE, Guimbellot J, Martiniano SL, Toprak D, Davis C, Daines CL, Muhlebach MS, Esther CR Jr, Dellon EP. Hoppe JE, et al. Pediatr Pulmonol. 2020 Sep;55(9):2225-2232. doi: 10.1002/ppul.24919. Epub 2020 Jul 3. Pediatr Pulmonol. 2020. PMID: 32573948 Review.

4

Toward inclusive therapy with CFTR modulators: Progress and challenges.

Guimbellot J, Sharma J, Rowe SM. Guimbellot J, et al. Pediatr Pulmonol. 2017 Nov;52(S48):S4-S14. doi: 10.1002/ppul.23773. Epub 2017 Sep 7. Pediatr Pulmonol. 2017. PMID: 28881097 Free PMC article. Review.

5

Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducer.

Guimbellot JS, Acosta EP, Rowe SM. Guimbellot JS, et al. Pediatr Pulmonol. 2018 May;53(5):E6-E8. doi: 10.1002/ppul.23971. Epub 2018 Feb 28. Pediatr Pulmonol. 2018. PMID: 29488691 Free PMC article.

6

Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutations.

Guimbellot J, Solomon GM, Baines A, Heltshe SL, VanDalfsen J, Joseloff E, Sagel SD, Rowe SM; GOALe(2) Investigators. Guimbellot J, et al. J Cyst Fibros. 2019 Jan;18(1):102-109. doi: 10.1016/j.jcf.2018.04.004. Epub 2018 Apr 21. J Cyst Fibros. 2019. PMID: 29685811 Free PMC article.

7

Co-cultured microfluidic model of the airway optimized for microscopy and micro-optical coherence tomography imaging.

Liu Z, Mackay S, Gordon DM, Anderson JD, Haithcock DW, Garson CJ, Tearney GJ, Solomon GM, Pant K, Prabhakarpandian B, Rowe SM, Guimbellot JS. Liu Z, et al. Among authors: guimbellot js. Biomed Opt Express. 2019 Sep 30;10(10):5414-5430. doi: 10.1364/BOE.10.005414. eCollection 2019 Oct 1. Biomed Opt Express. 2019. PMID: 31646055 Free PMC article.

8

Females with Cystic Fibrosis Demonstrate a Differential Response Profile to Ivacaftor Compared with Males.

Secunda KE, Guimbellot JS, Jovanovic B, Heltshe SL, Sagel SD, Rowe SM, Jain M. Secunda KE, et al. Among authors: guimbellot js. Am J Respir Crit Care Med. 2020 Apr 15;201(8):996-998. doi: 10.1164/rccm.201909-1845LE. Am J Respir Crit Care Med. 2020. PMID: 31841644 Free PMC article. No abstract available.

9

Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy.

Guimbellot JS, Ryan KJ, Anderson JD, Liu Z, Kersh L, Esther CR, Rowe SM, Acosta EP. Guimbellot JS, et al. J Cyst Fibros. 2020 Sep;19(5):742-745. doi: 10.1016/j.jcf.2020.01.011. Epub 2020 Feb 7. J Cyst Fibros. 2020. PMID: 32044246 Free PMC article.

10

Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis.

Liu Z, Anderson JD, Deng L, Mackay S, Bailey J, Kersh L, Rowe SM, Guimbellot JS. Liu Z, et al. Among authors: guimbellot js. Genes (Basel). 2020 May 29;11(6):603. doi: 10.3390/genes11060603. Genes (Basel). 2020. PMID: 32485957 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters